Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model (Q64056173)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

title

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

1 reference

corrigendum / erratum

Author Correction: Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model

0 references

author

Chia-Chen Liu

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

author name string

Li Zhong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Ying Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Rengong Zhuo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Tingting Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Kai Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Ruizhi Huang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Daxin Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Yue Gao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Yifei Zhu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Xuan Sheng

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Kai Chen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Na Wang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Lin Zhu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Dan Can

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Yuka Marten

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Mitsuru Shinohara

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Dan Du

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Hao Sun

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Lei Wen

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Huaxi Xu

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Guojun Bu

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Xiao-Fen Chen

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

language of work or name

English

0 references

publication date

25 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

1365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

30 April 2020

copyright license

start time

25 March 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6433910/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Neuroinflammation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Neuropathological alterations in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

The role of microglia in amyloid clearance from the AD brain

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Association of microglia with amyloid plaques in brains of APP23 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 Variants in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Coding variants in TREM2 increase risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 in Neurodegenerative Diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2).

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

New insights into the role of TREM2 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Soluble TREM2 induces inflammatory responses and enhances microglial survival.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Microglia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Iba1 is an actin-cross-linking protein in macrophages/microglia

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Microglia-specific targeting by novel capsid-modified AAV6 vectors

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer’s disease model

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

The synaptic Abeta hypothesis of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Innate immunity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

VPS35 haploinsufficiency increases Alzheimer's disease neuropathology.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

mGluR1, but not mGluR5, activates feed-forward inhibition in the medial prefrontal cortex to impair decision making

1 reference

https://api.crossref.org/works/10.1038%2FS41467-019-09118-9

7 January 2021

Alzheimer's disease: the challenge of the second century

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30911003

12 December 2020

inferred from PubMed ID database lookup

Microglia in Alzheimer's Disease: It's All About Context

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30911003

12 December 2020

inferred from PubMed ID database lookup

Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30911003

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41467-019-09118-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 April 2020

ADS bibcode

2019NatCo..10.1365Z

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30911003%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

PubMed publication ID

30911003

1 reference